The novel treatment of this peptide represents a major breakthrough in the handling of the condition. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide176093.blogsidea.com/48912330/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment